https://www.selleckchem.com/products/ly333531.html
001) and a significantly decreased REM latency (SMD=-0.93[-1.73,-0.13], p=0.022). No differences were observed for total sleep time, sleep efficiency, and slow-wave-sleep. . Most studies had small sample size, with no placebo group and with open designs. . REM sleep amount and latency appear altered both during the acute and remitted phase of SAD, representing trait markers with interesting diagnosis and therapeutic implications. . REM sleep amount and latency appear altered both during the acute and remitted phase of SAD, representing
Like
Comment
Share
